Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients is a research paper published in Inflammatory Bowel Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: T32DK007727
National Institutes of Health
Grant: UL1 TR000445
National Institutes of Health
Grant: P30 DK078392
Crohn's & Colitis Foundation
Grant: 614971
National Institutes of Health
Grant: 3P30DK078392-03S1
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Disease
National Institutes of Health
Grant: 6UL1TR000445-11
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 5T32DK007727-29
Pediatric Gastroenterology and Nutrition Training Grant
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals